Cisplatin-Based Chemotherapy for Testicular Germ Cell Tumors: Complication Rates of Peripheral versus Central Venous Administration

Publisher： Karger

E-ISSN： 1423-0399|96|2|177-182

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.96, Iss.2, 2016-0, pp. : 177-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin-Based Chemotherapy for Pulmonary Metastasized Germ Cell Tumors of the Testis – Be Aware of Acute Respiratory Distress Syndrome

By  

Oncology Research and Treatment, Vol. 32, Iss. 3, 2009-02 ,pp. : 125-128

Karger

Access to resources Recommend Favorite

Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer

By  

Urologia Internationalis, Vol. 99, Iss. 1, 2017-05 ,pp. : 104-109

Karger

Access to resources Recommend Favorite

High Rates of Thromboembolic Events in Patients with Germ Cell Cancer Undergoing Cisplatin-Based Polychemotherapy

By  

Urologia Internationalis, Vol. 96, Iss. 4, 2016-04 ,pp. : 399-405

Karger

Access to resources Recommend Favorite

Current Trends in Chemotherapy for Metastatic Nonseminomatous Testicular Germ Cell Tumors

By  

Oncology, Vol. 55, Iss. 3, 1998-04 ,pp. : 177-188

Karger

Access to resources Recommend Favorite

Salvage Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin (TIP) in Relapsed or Cisplatin-Refractory Germ Cell Tumors

By  

Oncology Research and Treatment, Vol. 34, Iss. 8-9, 2011-08 ,pp. : 416-420

Karger

Access to resources Recommend Favorite